Search research articles
Contact Us
Filters
Showing results (51-60 of 81) with videos related to
Page
of 9
Sort By:
Plos One
|
March 10, 2018
NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients
Marta Schirripa, Wu Zhang, Dongyun Yang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2019
Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3
Alberto Puccini, Fotios Loupakis, Sebastian Stintzing, et al.
JCO Precision Oncology
|
April 28, 2025
Association of Androgen Receptor Expression With Tumor Immune Landscape and Treatment Outcomes of Patients With Breast Cancer
Priya Jayachandran, Sachin K Deshmukh, Sharon Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 4, 2025
Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials
Marco Maria Germani, Beatrice Borelli, Tadayoshi Hashimoto, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
December 29, 2016
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world
Valentina Fanotto, Stefano Cordio, Giulia Pasquini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 30, 2019
Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer
Ryuma Tokunaga, Joanne Xiu, Curtis Johnston, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 20, 2020
The impact of ARID1A mutation on molecular characteristics in colorectal cancer
Ryuma Tokunaga, Joanne Xiu, Richard M Goldberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer
Filippo Pietrantonio, Claudio Vernieri, Giulia Siravegna, et al.
Neoplasia (New York, N.Y.)
|
November 7, 2025
Age-diet interactions significantly influence intratumoral gene expression, gut microbiome signature and tumor microenvironment in colorectal cancer
Shivani Soni, Pooja Mittal, Jae Ho Lo, et al.
International Journal of Cancer
|
March 12, 2019
AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC and FIRE3
Ryuma Tokunaga, Shu Cao, Madiha Naseem, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 81) with videos related to
Sort By:
Page
of 9
Plos One
|
March 10, 2018
NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients
Marta Schirripa, Wu Zhang, Dongyun Yang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2019
Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3
Alberto Puccini, Fotios Loupakis, Sebastian Stintzing, et al.
JCO Precision Oncology
|
April 28, 2025
Association of Androgen Receptor Expression With Tumor Immune Landscape and Treatment Outcomes of Patients With Breast Cancer
Priya Jayachandran, Sachin K Deshmukh, Sharon Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 4, 2025
Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials
Marco Maria Germani, Beatrice Borelli, Tadayoshi Hashimoto, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
December 29, 2016
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world
Valentina Fanotto, Stefano Cordio, Giulia Pasquini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 30, 2019
Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer
Ryuma Tokunaga, Joanne Xiu, Curtis Johnston, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 20, 2020
The impact of ARID1A mutation on molecular characteristics in colorectal cancer
Ryuma Tokunaga, Joanne Xiu, Richard M Goldberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer
Filippo Pietrantonio, Claudio Vernieri, Giulia Siravegna, et al.
Neoplasia (New York, N.Y.)
|
November 7, 2025
Age-diet interactions significantly influence intratumoral gene expression, gut microbiome signature and tumor microenvironment in colorectal cancer
Shivani Soni, Pooja Mittal, Jae Ho Lo, et al.
International Journal of Cancer
|
March 12, 2019
AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC and FIRE3
Ryuma Tokunaga, Shu Cao, Madiha Naseem, et al.
Page
of 9